Skip to main content

Fiscal Wizard · Single-issue tearsheet

HSIC / Aug 31, 2026 Run #19100

HSIC

Henry Schein, Inc.

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. It has a strategic partnership with GoTu Technology to help dental practices address ongoing staffing challenges. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Composite verdict

C 59.1 / 100
Bullish setup · Crossover 8 drivers · 3 gates blocking
  • Vortex Signal
  • Engulfing
  • Fibonacci Retracement
Consider long call target Δ ~0.50 · ~35 DTE Bullish setup, Grade C → ITM call target

Industry rank 3rd of 4 in Medical Distribution

rescore-sweep
Technical synthesisRegime: uptrend
Bull 100%Evidence: High · 21 signals0% Bear
Momentum Bullish 97Mean-reversion Neutral 52
  • Late-stage trendTrend signals have been live for 60 bars — past the ~60-bar window; momentum edge decays and can reverse late in a move. (medium confidence)
Where value comes fromMargin of safety -62%
Asset value $29.12Earnings power value $30.39Price $89.32

Priced above its no-growth earnings power value ($30.39/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Weak

18.3 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
P/S Ratio 94
PEG 0
EV/Sales 91
Margin of Safety 0
Capex to Sales 90
Operating Margin 0

Technicals Bullish

100.0 / 100

Bullish setup leads (Vortex Signal, Engulfing, 52-Week Proximity); bears gated by guards. · 44 signals shown.

Strongest
Weakest
Vortex Signal 85
Engulfing 80
Coppock Curve 76

Risk Gates

3 blocking 9 caution

3 guards active, 21 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Realized Volatility Regime Blocking

High-vol regime mutes mean-reversion signals; low-vol regime mutes breakout signals.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Altman Z-Score Caution

Bottom-band Altman Z blocks bullish signals — distress risk.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for HSIC.